Zepbound 00002-0243-04
Generic: Tirzepatide
- Manufacturer
- Eli Lilly And Company
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- March 28, 2024
- Listing Expires
- December 31, 2027
- Application
- NDA217806
Need to source Zepbound? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Tirzepatide | 5 mg/.5mL |
Drug Class
Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]GLP-1 Receptor Agonist [EPC]G-Protein-linked Receptor Interactions [MoA]
Selected Package
00002-0243-04Selected4 VIAL, SINGLE-DOSE in 1 CARTON (0002-0243-04) / .5 mL in 1 VIAL, SINGLE-DOSE
Other packages for this product(1)
1 VIAL, SINGLE-DOSE in 1 CARTON (0002-0243-01) / .5 mL in 1 VIAL, SINGLE-DOSE